The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 in early stage breast cancer: The INVINCIBLE trial.
 
Melanie Spears
Research Funding - Intensity Therapeutics
Patents, Royalties, Other Intellectual Property - Patent: Histone gene module predicts anthracycline benefit, Patent, A 18 gene expression signature that predicts response to anthracycline treatment.
 
Megan Hopkins
No Relationships to Disclose
 
Kianoosh Keyhanian
No Relationships to Disclose
 
Susan Robertson
No Relationships to Disclose
 
Linda Liao
No Relationships to Disclose
 
Vida Talebian
No Relationships to Disclose
 
Arif Ali Awan
Honoraria - Apotex; AstraZeneca Canada; Exactis Innovation; Lilly O.; Novartis; Oncology Education; Roche Canada
Consulting or Advisory Role - AstraZeneca; AstraZeneca Canada; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly O.; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche Canada
Research Funding - Astellas Pharma (Inst); Canexia Health (Inst); Exact Therapeutics (Inst); Intensity Therapeutics (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Roche
 
Gregory Russell Pond
Employment - Roche Canada (I)
Stock and Other Ownership Interests - Roche Canada (I)
Honoraria - AstraZeneca; AstraZeneca
Consulting or Advisory Role - Merck; Profound Medical; Takeda
 
John Bartlett
No Relationships to Disclose
 
Lewis H. Bender
Employment - Intensity Therapeutics
Leadership - Intensity Therapeutics
Stock and Other Ownership Interests - Intensity Therapeutics
Research Funding - Intensity Therapeutics
Travel, Accommodations, Expenses - Intensity Therapeutics
 
Ian B. Walters
Employment - Intensity Therapeutics; Portage Biotech
Leadership - Intensity Therapeutics; Portage Biotech
Stock and Other Ownership Interests - Intensity Therapeutics; Portage Biotech
 
Vanessa Lopez-Ozuna
No Relationships to Disclose
 
Angel Arnaout
No Relationships to Disclose